中村 理恵子

Medicine & Life Sciences

1. Esophagectomy 100%
2. Esophageal Neoplasms 82%
3. Stomach Neoplasms 72%
4. Esophageal Squamous Cell Carcinoma 55%
5. Lymph Nodes 27%
6. Neoplasm Metastasis 26%
7. Survival 24%
8. Stomach 22%
9. Neoplasms 21%
10. Gastrectomy 20%
11. Recurrence 18%
12. Chemoradiotherapy 17%
13. Cisplatin 16%
14. Postoperative Complications 16%
15. Pneumonia 14%
16. Lymph Node Excision 14%
17. Endoscopic Mucosal Resection 14%
18. Drug Therapy 13%
19. Anastomotic Leak 12%
20. Thoracic Duct 11%
21. Carcinoma 11%
22. Fibrinogen 10%
23. Esophagogastric Junction 10%
24. Combination Drug Therapy 9%
25. Enteral Nutrition 8%
26. CCR7 Receptors 7%
27. Thorax 7%
28. Therapeutics 6%
29. Gastric Stump 6%
30. Cohort Studies 6%
31. Neoadjuvant Therapy 6%
32. Peptic Esophagitis 6%
33. Prospective Studies 6%
34. Esophagus 6%
35. Acute Lung Injury 5%
36. Retrospective Studies 5%
37. Octreotide 5%
38. Albumins 5%
39. C-Reactive Protein 5%
40. Ulcer 5%
41. Multivariate Analysis 5%
42. Adjuvant Chemotherapy 5%
43. Stomach Ulcer 5%